Clinically Validated Digital Therapeutics Summit

Memo

Digital Therapeutics are storming into the healthcare mainstream, offering a novel and effective way of preventing and treating some of the world's most medically unmet and chronic disease conditions. The inaugural Clinically Validated Digital Therapeutics Summit 2018 is a dedicated scientific and networking forum for pharmaceutical, biotech and healthcare pioneers to capitalize on this emerging therapeutic class. Attend the Clinically Validated Digital Therapeutics Summit 2018 to hear from pharma digital leaders, DTx pioneers and healthcare innovators as they guide you, step-by-step, through the process of developing and delivering robustly validated digital therapeutics to market. http://www.clinicallyvalidated-dtx.com/ Contact:This email address is being protected from spambots. You need JavaScript enabled to view it.+1 617 455 4188 URLs:Brochure:  https://go.evvnt.com/271773-0?pid=5569Tickets:  https://go.evvnt.com/271773-1?pid=5569 Time: 8:00 am to 5:00 pm. Venue details: Revere Hotel Boston Common, 200 Stuart Street, Boston, 02116, United States. Prices:Conference Earlybird (Book by 10/05/18): USD 1399.0,Conference (Standard rate): USD 2099.0. Speakers: Joris Van Dam (Novartis), Alex Waldron (Pear Therapeutics), Megan Coder (Digital Therapeutics Alliance), David Benshoof Klein (Click Therapeutics), Ainslie Hatch (Otsuka), Dirk Schapeler (Bayer), Melinda Decker (AstraZeneca), Eddie Martucci (Akili Interactive), Kai Gait (GSK)